Stock Price

0 EUR

-77.26% ROA

-68.16% ROE

0x PER

Market Cap.

1.178.563 EUR

30.09% DER

0% Yield

-75.5% NPM

curasan AG Stock Analysis

curasan AG Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

curasan AG Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.11x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock maintains a fair debt to equity ratio (72%), indicating a reasonable balance between the money it owes and the ownership it possesses.

3 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

4 ROE

The stock's ROE indicates a negative return (-68.16%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-77.26%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

curasan AG Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

curasan AG Technical Stock Analysis
# Analysis Recommendation

curasan AG Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

curasan AG Revenue
Year Revenue Growth
2006 0
2007 0 0%
2008 6.110.000 100%
2009 5.105.000 -19.69%
2010 3.930.000 -29.9%
2011 3.781.000 -3.94%
2012 3.226.000 -17.2%
2013 5.831.000 44.68%
2014 5.993.000 2.7%
2015 5.619.000 -6.66%
2016 6.504.000 13.61%
2017 6.476.000 -0.43%
2018 5.842.000 -10.85%
2019 6.200.000 5.77%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

curasan AG Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 107.000 100%
2013 126.000 15.08%
2014 121.000 -4.13%
2015 456.000 73.46%
2016 371.000 -22.91%
2017 0 0%
2018 422.000 100%
2019 406.000 -3.94%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

curasan AG General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 2.124.000 100%
2013 1.844.000 -15.18%
2014 1.738.000 -6.1%
2015 2.071.000 16.08%
2016 1.773.000 -16.81%
2017 0 0%
2018 1.700.000 100%
2019 2.356.000 27.84%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

curasan AG EBITDA
Year EBITDA Growth
2006 7.477.000
2007 7.701.000 2.91%
2008 139.000 -5440.29%
2009 57.000 -143.86%
2010 -3.397.000 101.68%
2011 -2.974.000 -14.22%
2012 -2.733.000 -8.82%
2013 -1.563.000 -74.86%
2014 -1.192.000 -31.12%
2015 2.147.000 155.52%
2016 -2.130.000 200.8%
2017 -3.416.000 37.65%
2018 -3.836.000 10.95%
2019 -2.536.000 -51.26%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

curasan AG Gross Profit
Year Gross Profit Growth
2006 3.448.000
2007 3.615.000 4.62%
2008 3.254.000 -11.09%
2009 3.000.000 -8.47%
2010 2.607.000 -15.07%
2011 2.374.000 -9.81%
2012 2.233.000 -6.31%
2013 3.896.000 42.68%
2014 3.940.000 1.12%
2015 3.370.000 -16.91%
2016 3.855.000 12.58%
2017 4.148.000 7.06%
2018 3.131.000 -32.48%
2019 4.230.000 25.98%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

curasan AG Net Profit
Year Net Profit Growth
2006 0
2007 0 0%
2008 9.546.000 100%
2009 191.000 -4897.91%
2010 870.000 78.05%
2011 -2.505.000 134.73%
2012 -3.473.000 27.87%
2013 -1.992.000 -74.35%
2014 -1.727.000 -15.34%
2015 1.333.000 229.56%
2016 -2.085.000 163.93%
2017 -6.236.000 66.57%
2018 -5.381.000 -15.89%
2019 -4.681.000 -14.95%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

curasan AG Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 -33
2007 -41 19.51%
2008 4 1466.67%
2009 0 0%
2010 0 0%
2011 -1 100%
2012 -1 0%
2013 -1 0%
2014 -1 0%
2015 0 0%
2016 -1 0%
2017 0 0%
2018 -1 0%
2019 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

curasan AG Free Cashflow
Year Free Cashflow Growth
2006 -2.531.000
2007 -2.185.000 -15.84%
2008 -3.615.000 39.56%
2009 2.036.000 277.55%
2010 -2.328.000 187.46%
2011 -3.972.000 41.39%
2012 -3.424.000 -16%
2013 -2.198.000 -55.78%
2014 -698.000 -214.9%
2015 1.999.000 134.92%
2016 -2.234.000 189.48%
2017 -402.000 -455.72%
2018 -4.663.000 91.38%
2019 -3.090.000 -50.91%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

curasan AG Operating Cashflow
Year Operating Cashflow Growth
2006 -2.531.000
2007 -2.185.000 -15.84%
2008 -3.583.000 39.02%
2009 2.196.000 263.16%
2010 -1.023.000 314.66%
2011 -3.356.000 69.52%
2012 -2.717.000 -23.52%
2013 -1.852.000 -46.71%
2014 -583.000 -217.67%
2015 2.151.000 127.1%
2016 -2.111.000 201.89%
2017 -294.000 -618.03%
2018 -4.342.000 93.23%
2019 -2.952.000 -47.09%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

curasan AG Capital Expenditure
Year Capital Expenditure Growth
2006 0
2007 0 0%
2008 32.000 100%
2009 160.000 80%
2010 1.305.000 87.74%
2011 616.000 -111.85%
2012 707.000 12.87%
2013 346.000 -104.34%
2014 115.000 -200.87%
2015 152.000 24.34%
2016 123.000 -23.58%
2017 108.000 -13.89%
2018 321.000 66.36%
2019 138.000 -132.61%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

curasan AG Equity
Year Equity Growth
2006 4.761.000
2007 2.949.000 -61.44%
2008 12.550.000 76.5%
2009 12.890.000 2.64%
2010 14.207.000 9.27%
2011 10.890.000 -30.46%
2012 7.381.000 -47.54%
2013 6.886.000 -7.19%
2014 6.655.000 -3.47%
2015 8.840.000 24.72%
2016 8.953.000 1.26%
2017 9.941.000 9.94%
2018 7.521.000 -32.18%
2019 6.214.000 -21.03%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

curasan AG Assets
Year Assets Growth
2006 11.255.000
2007 8.527.000 -31.99%
2008 14.665.000 41.85%
2009 14.262.000 -2.83%
2010 17.166.000 16.92%
2011 13.284.000 -29.22%
2012 9.212.000 -44.2%
2013 13.659.000 32.56%
2014 13.511.000 -1.1%
2015 12.577.000 -7.43%
2016 12.614.000 0.29%
2017 14.548.000 13.29%
2018 11.259.000 -29.21%
2019 10.665.000 -5.57%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

curasan AG Liabilities
Year Liabilities Growth
2006 0
2007 0 0%
2008 2.115.000 100%
2009 1.372.000 -54.15%
2010 2.959.000 53.63%
2011 2.394.000 -23.6%
2012 1.831.000 -30.75%
2013 6.773.000 72.97%
2014 6.856.000 1.21%
2015 3.737.000 -83.46%
2016 3.661.000 -2.08%
2017 4.607.000 20.53%
2018 3.738.000 -23.25%
2019 4.451.000 16.02%

curasan AG Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
0
Price to Earning Ratio
0x
Price To Sales Ratio
0.19x
POCF Ratio
0
PFCF Ratio
-0.38
Price to Book Ratio
0
EV to Sales
0.37
EV Over EBITDA
-0.91
EV to Operating CashFlow
-0.78
EV to FreeCashFlow
-0.75
Earnings Yield
0
FreeCashFlow Yield
-2.62
Market Cap
0 Bil.
Enterprise Value
0 Bil.
Graham Number
0
Graham NetNet
0

Income Statement Metrics

Net Income per Share
0
Income Quality
0.63
ROE
-0.68
Return On Assets
-0.44
Return On Capital Employed
-0.52
Net Income per EBT
1
EBT Per Ebit
1.09
Ebit per Revenue
-0.69
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0.38
Research & Developement to Revenue
0.07
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.68
Operating Profit Margin
-0.69
Pretax Profit Margin
-0.75
Net Profit Margin
-0.76

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0.05
Capex to Revenue
-0.02
Capex to Depreciation
-0.1
Return on Invested Capital
-0.53
Return on Tangible Assets
-0.77
Days Sales Outstanding
94.78
Days Payables Outstanding
198.06
Days of Inventory on Hand
460.42
Receivables Turnover
3.85
Payables Turnover
1.84
Inventory Turnover
0.79
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
0
Debt to Equity
0.3
Debt to Assets
0.18
Net Debt to EBITDA
-0.45
Current Ratio
2.09
Tangible Asset Value
0 Bil.
Net Current Asset Value
0 Bil.
Invested Capital
0.3
Working Capital
0 Bil.
Intangibles to Total Assets
0.43
Average Receivables
0 Bil.
Average Payables
0 Bil.
Average Inventory
2221500
Debt to Market Cap
1.59

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

curasan AG Dividends
Year Dividends Growth
2011 0

curasan AG Profile

About curasan AG

CEO
Employee
0
Address

,

curasan AG Executives & BODs

curasan AG Executives & BODs
# Name Age

curasan AG Competitors